-
Symbol
-
KPTI on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
1.57M shares
-
Security Ownership
-
9.48%
Opaleye Management Inc. ownership in Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI)
2025-10-17 - Opaleye Management Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.57M shares of Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI).
This represents 9.48% percent ownership of the company.